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Abstract 
Introduction: Thyroid nodules are a common clinical entity found among the adult 
general population. With increasing use of imaging investigations like ultrasonography, there 
has been a significant rise in the detection of non-palpable thyroid nodules that require further 
evaluation  and  management.  The  routine  use  of  FNAC  has  reduced  the  number  of 
unnecessary  surgical  procedures  for  thyroid  nodules.  Taking  a  decision  as  to  whether  to 
operate on a thyroid nodule is dependent on accurate FNAC testing. This study describes the 
experience  with  FNAC  in  a  consecutive  series  of  patients  with  thyroid  nodules  who 
underwent thyroidectomy at a tertiary care hospital in the department of endocrine surgery.  
 
Patients  and  methods:  Clinical  and  pathologic  data  of  patients  with  thyroid  nodules  or 
diffuse goitre who were operated in a single endocrine surgical unit between January 2008 
and  December  2010  were  prospectively  collected  and  retrospectively  reviewed.  The 
anatomical lesion of the thyroid (solitary nodule, STN, multinodular goitre, MNG or diffuse www.jorl.scopemed.org 
 
goitre, DG) was recorded. The functional status of the thyroid was assessed for each patient 
at presentation. All patients included in the study underwent fine needle aspiration cytology 
(FNAC)  followed  by  surgery.  Patients  with  solitary  toxic  nodules  underwent 
hemithyroidectomy, while others underwent total thyroidectomy. Final histopathology (HPE) 
was then compared with initial FNAC results.  
 
Results: Out of the total number of 702 patients, 119 (17%) were men and the remaining 583 
(83%) were women. With regards to solitary thyroid nodules, FNAC had a sensitivity of 
86.9%, specificity of 99.1%, false negative rate of 13.1%, false-positive rate of 0.9%, positive 
predictive  value  of  97,6%  and  negative  predictive  value  of  94.9%  for  diagnosis  of 
malignancy. FNAC had a sensitivity of 76.9%, specificity of 98.8%, false negative rate of 
23.1%, false-positive rate of 1.2%, positive predictive value of 94.6% and negative predictive 
value of 93.8% for diagnosis of malignancy with respect to diffuse and multinodular goitre. 
Overall, FNAC had a sensitivity of 80.2%, specificity of 98.9%, false negative rate of 19.8%, 
false-positive rate of 1.1%, positive predictive value of 96.6% and negative predictive value 
of 94.1% for diagnosis of malignancy.  
 
Conclusion: FNAC was more accurate in patients with solitary thyroid nodules than in those 
with multinodular or diffuse goitre. While false negativity could be due to misrepresentative 
sample or misinterpretation of the sample, false positivity could be ascribed to hyperplasia of 
thyrocytes in the functioning thyroid as a result of TSH stimulation. 
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Introduction 
Thyroid  nodules  are  a  common  clinical  entity  found  among  the  adult  general 
population. The frequency of non-palpable thyroid nodules may be as high as 50% or more 
by the age of 50 years.
1,2 With time, ultrasonography has come to be used with increasing 
regularity in clinical practice. As a result, there has been a significant rise in the incidence of 
non-palpable thyroid nodules that require further evaluation and management. Since 1986, 
when fine needle aspiration cytology (FNAC) was first reported from Sweden, it has been 
widely  accepted  as  the  most  accurate,  cost-effective,  and  safe  screening  test  for  rapid 
diagnosis of thyroid nodules.
3, 4, 5 
The routine use of FNAC has reduced the number of unnecessary surgical procedures 
for thyroid nodules.
2, 6 In addition; it has enabled the detection of thyroid cancer at earlier 
stages.
7, 8 Taking a decision as to whether to operate on a thyroid nodule is dependent on 
accurate  FNAC  testing.  Assessment  of  false  positive  and  false  negative  FNAC  results 
assumes importance in this context.
9  
  Indeterminate FNAC results that include follicular and Hurthle cell neoplasms and 
those that indicate a suspicion of papillary thyroid cancer (PTC) without actually diagnosing 
PTC, represent a continued diagnostic and treatment challenge to pathologists and surgeons 
alike. The diagnosis of follicular thyroid carcinoma (FTC) or Hurthle cell carcinoma (HTC) 
requires the presence of capsular or vascular invasion on final histopathological examination 
(HPE), findings that cannot be assessed by FNAC. Sometimes, patients with indeterminate 
thyroid nodules who undergo hemi-thyroidectomy are found to have malignancy on final 
pathology. Such cases necessitate completion thyroidectomy.
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This study describes the experience with FNAC in a consecutive series of patients 
with  thyroid  nodules  who  underwent  thyroidectomy  at  a  tertiary  care  hospital  in  the 
department of endocrine surgery.  
 
Methods 
Clinical  and  pathologic  data  of  702  consecutive  patients  with  thyroid  nodules  or 
diffuse goitre who were managed in a single endocrine surgical unit between January 2008 
and  December  2010  were  prospectively  collected  and  retrospectively  reviewed.  The 
anatomical lesion of the thyroid (solitary nodule, STN, multinodular goitre, MNG or diffuse 
goitre, DG) was recorded. The functional status of the thyroid was assessed for each patient 
at presentation with the help of free thyroid hormone (FT3 and FT4) and thyroid stimulating 
hormone (TSH) levels. Levels of anti-microsomal and anti-thyroglobulin antibodies (AMA 
and ATG) were estimated. Those who were hypothyroid or hyperthyroid at presentation were 
started on appropriate drug therapy.  
All FNAC slides were classified into 1 of 4 main categories: non-diagnostic, benign, 
indeterminate, or malignant. The indeterminate group included specimens further classified 
as follicular neoplasm (FN), Hurthle cell neoplasm (HN), or suspicious for papillary thyroid 
cancer (SPTC). Specimens were classified as follicular neoplasms when cytology aspirates 
were very cellular, with scant or no colloid, and uniform microfollicular cells were present. 
The interpretation of Hürthle cell neoplasm was made when FNAC aspirates consisted of 
microfollicles formed by cells with abundant eosinophilic cytoplasm lacking lymphocytes. 
The diagnosis of ‘suspicious for PTC’ (SPTC) was made when cellular aspirates revealed 
nuclear grooving, intranuclear pseudo-inclusions, or Psammoma bodies, but no papillae and 
little colloid. www.jorl.scopemed.org 
 
Papillary microcarcinomas, defined as malignant lesions smaller than 1 cm, were considered 
in the final analysis of this study.  
Patients with non-toxic solitary thyroid nodules (including FN, HN and PTC), DG and 
MNG  underwent  total  thyroidectomy.  Those  with  a  solitary  toxic  adenoma  underwent 
hemithyroidectomy. All patients with pre-operative diagnosis of malignancy underwent total 
thyroidectomy  (TT)  and  central  compartment  neck  lymph-node  dissection  (CCLND),  if 
indicated.  Those  patients  with  lateral  cervical  node  metastases  diagnosed  preoperatively 
underwent a modified radical neck dissection (MRND) of the involved side.  
Indications for thyroidectomy when FNAC of the index nodule was benign included 
interval growth, obstructive symptoms, cosmetic reasons, adverse ultrasonographic nodule 
features, and/or patient preference. 
All  702  patients  underwent  hemithyroidectomy  or  total  thyroidectomy,  and  final 
histopathology (HPE) was then compared with initial FNAC results.  
 
Results 
A total of 702 patients, aged between 13 and 78 yrs, with median age of 39  yrs 
underwent  FNAC  of  the  thyroid  followed  by  thyroidectomy  between  January  2008  and 
December 2010. Out of the total number of patients, 119 (17%) were men and the remaining 
583 (83%) were women. 
Out of the total number of cases studied on FNAC, 460 (66%) were diagnosed with 
benign thyroid disease while 115 patients (16%) were diagnosed to have malignancy (Table 
1).  71  (10%)  FNAC  results  were  classified  as  indeterminate  and  56  patients  had  a  non-
diagnostic FNAC (Table 1). Out of the 115 patients who were diagnosed with malignancy, 
107  (93%)  had  PTC  while  8  (7%)  had  medullary  thyroid  cancer  (Table  1).  Among  the www.jorl.scopemed.org 
 
indeterminate  reports,  34  patients  (48%)  were  reported  to  have  FN,  while  5  (7%)  were 
diagnosed as HN and the remaining 32 (45%) were suspicious for PTC (Table 1).  
Among  the  460  patients  with  benign  disease  as  diagnosed  on  FNAC,  433  (94%) 
patients had benign disease after HPE, while 27 (6%) patients turned out to have malignancy 
(Table 1). Out of the 115 patients diagnosed with malignancy on FNAC, 110 (96%) patients 
had malignancy on HPE while 5 (4%) patients had benign disease on HPE of the operative 
specimen (Table 1). All these 5 patients had been diagnosed with PTC on FNAC. All the 
patients diagnosed with MTC on FNAC had MTC on HPE of the operative specimen. Out o 
the 71 patients with indeterminate FNAC diagnosis, 32 (45%) had malignancy on HPE, while 
39 (55%) patients had benign disease (Table 1).  
Out of the total number, 196 patients had solitary thyroid nodules (Table 2). While 
118 patients (60%) had benign diagnosis on FNAC, 41 patients (21%) were diagnosed with 
malignancy,  29  (15%)  had  indeterminate  FNAC  and  8  patients  (4%)  had  non-diagnostic 
results  (Table  2).  On  comparison  with  final  HPE,  FNAC  had  a  sensitivity  of  86.9%, 
specificity  of  99.1%,  false  negative  rate  of  13.1%,  false-positive  rate  of  0.9%,  positive 
predictive  value  of  97.6%  and  negative  predictive  value  of  94.9%  for  diagnosis  of 
malignancy.  
The remaining 502 patients had MNG or DG (Table 3). Out of these, 342 (68%) were 
diagnosed  with  benign  disease  on  FNAC,  while  74  patients  (15%)  were  diagnosed  with 
malignancy (Table 3). 42 patients (8%) had indeterminate results, while FNAC was non-
diagnostic in 48 patients (9%). When compared with the final HPE, FNAC had a sensitivity 
of 76.9%, specificity of 98.8%, false negative rate of 23.1%, false-positive rate of 1.2%, 
positive predictive value of 94.6% and negative predictive value of 93.8% for diagnosis of 
malignancy.  www.jorl.scopemed.org 
 
Overall, FNAC had a sensitivity of 80.2%, specificity of 98.9%, false negative rate of 
19.8%, false-positive rate of 1.1%, positive predictive value of 96.6% and negative predictive 
value of 94.1% for diagnosis of malignancy.  
In all, 179 out of the total of 702 patients (25%) were found to have malignant thyroid 
disease on final HPE (Table 4). Out of these, 113 (63%) had PTC, 48 (27%) had follicular 
variant of PTC, 8 patients (4%) had MTC, 4 (2%) had follicular carcinoma, 2 (1%) had 
Hurthle cell carcinoma and 4 patients had other variants of PTC. 
 
Discussion 
  In  this  study,  FNAC  was  conducted  with  the  help  of  a  24-guage  needle.  Non-
aspiration cytology was not performed. 
In  the  present  study,  the  overall  false  negative  rate  for  FNAC  was  19.8%.  Other 
reports in the literature suggest false negative rates ranging from 1% to 17%.
6,8-16 On analysis 
of FNAC results with respect to the anatomical diagnosis, FNAC had a false negative rate of 
13.1% for solitary thyroid nodules and 23.1% for diffuse goitre or multinodular goitre. 
This could be due to misrepresentative sample or misinterpretation of the sample. 
False negatives in the case of STNs could be due to misinterpretation, while those in patients 
with MNG or DG could be misrepresentative samples. 
The false positive rate of FNAC was 1.1% in the present study. This incidence is 
consistent with other reports that cite false positive FNA results ranging from 0% to 9%.
9-13 
This  could  be  ascribed  to  changes  in  the  thyroid  as  a  result  of  TSH  stimulation. 
Hypothyroidism is characterised by hyperthyrotropinemia. Cellular hyperplasia is common in 
a functioning gland under TSH stimulation, resulting in highly cellular smears with scanty 
colloid, resembling malignancy. 
Conclusion www.jorl.scopemed.org 
 
Overall, FNAC had a sensitivity of 80.2%, specificity of 98.9%, false negative rate of 
19.8%, false-positive rate of 1.1%, positive predictive value of 96.6% and negative predictive 
value  of  94.1%  for  diagnosis  of  malignancy.  FNAC  was  more  accurate  in  patients  with 
solitary  thyroid  nodules  than  in  those  with  multinodular  or  diffuse  goitre.  While  false 
negativity could be due to misrepresentative sample or misinterpretation of the sample, false 
positivity could be ascribed to hyperplasia of thyrocytes in the functioning thyroid as a result 
of TSH stimulation. . On the basis of these findings, we suggest that it is advisable to avoid 
FNAC in hypothyroid state. 
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